BioCentury
ARTICLE | Clinical News

Ceplene histamine dihydrochloride: Started Phase II trial

December 24, 2001 8:00 AM UTC

Maxim Pharmaceuticals Inc. (MAXM; SSE:MAXM), San Diego, Calif. Product: Ceplene (formerly Maxamine) histamine dihydrochloride Business: Infectious diseases Therapeutic category: Immune stimulation, ...